#	Pagina
attuale pagina	/open-h2020/projects/224496/index.html

Opendata, web and dolomites

MOXO-Mobile Phase-1 SIGNED

MOXO-Mobile: the first Attention Deficit Hyperactive Disorder (ADHD) screening mobile application, using Eye Tracking and Continuous Performance Test components to give the first evidence of attention

Total Cost €

EC-Contrib. €

Partnership

Views

MOXO-Mobile Phase-1 project word cloud

Explore the words cloud of the MOXO-Mobile Phase-1 project. It provides you a very rough idea of what is the project "MOXO-Mobile Phase-1" about.

plan feasibility downloaded leads difficulties mobile incarceration diagnosis undiagnosed combining unemployment 26 attentional smei he quality cpt strategy solutions death performance estimation tests prevent give criminality smartphone max eye et social pay market profile free guidance tracking projected wishes receive school screening accurate himself drop lives learning business risk adhd family 8b neurotech individuals dramatically million first life continuous conduct sustainability moxo evaluation premature save create elaborated purchase least recidivism roi

Project "MOXO-Mobile Phase-1" data sheet

The following table provides information about the project.

Coordinator	NEURO TECHNOLOGY SOLUTIONS LTD Organization address address: HAPLADA 3 city: OR YEHUDA postcode: 6021803 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Israel [IL]
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-08-01 to 2020-01-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	NEURO TECHNOLOGY SOLUTIONS LTD NEURO TECHNOLOGY SOLUTIONS LTD Organization address address: HAPLADA 3 city: OR YEHUDA postcode: 6021803 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IL (OR YEHUDA)	coordinator	50˙000.00

Map

Project objective

Undiagnosed ADHD leads to learning and social difficulties, school drop-out, unemployment, criminality, and even premature death.

Early diagnosis can dramatically improve the quality of life of at least 26 million individuals in the EU, prevent incarceration and recidivism, and save lives.

MOXO-Mobile is the first ADHD screening mobile application, combining a Continuous Performance Test (CPT) and Eye Tracking (ET) to give an accurate and simple evaluation of the evidence of attentional difficulties. Using this application, every smartphone user could assess his/her attention level and profile and receive further guidance, in case of need, for further diagnosis.

The application will be downloaded for free with pay-per-use strategy as the user will purchase tests as he wishes for himself and his family.

MOXO-Mobile will create a new market (ADHD screening), with max market potential of €2.8B, and a projected ROI of 6.1 in 3 years for MOXO-Mobile.

SMEi Phase 1 will enable Neurotech-Solutions to conduct a wide feasibility study, establish an elaborated business plan, risk assessment, and a sustainability estimation of the product.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOXO-MOBILE PHASE-1" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOXO-MOBILE PHASE-1" are provided by the European Opendata Portal: CORDIS opendata.